Cargando…

European guidelines on functional bowel disorders with diarrhoea: United European Gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) statements and recommendations

Detalles Bibliográficos
Autores principales:	Tornkvist, Navkiran T., Törnblom, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Neurogastroenterology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486482/ https://www.ncbi.nlm.nih.gov/pubmed/35765230 http://dx.doi.org/10.1002/ueg2.12270

Ejemplares similares

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis
por: Schol, Jolien, et al.
Publicado: (2021)

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia
por: Wauters, Lucas, et al.
Publicado: (2021)

Worldwide prevalence and burden of gastroparesis‐like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis
por: Huang, I‐Hsuan, et al.
Publicado: (2022)

Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility
por: Savarino, Edoardo, et al.
Publicado: (2022)

European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus
por: Hammer, Heinz F., et al.
Publicado: (2021)

European Guideline on Achalasia – UEG and ESNM recommendations
por: Oude Nijhuis, RAB, et al.
Publicado: (2020)

European guideline on indications, performance and clinical impact of (13)C‐breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC
por: Keller, Jutta, et al.
Publicado: (2021)

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
por: Tornkvist, Navkiran T., et al.
Publicado: (2021)

Association between Brachyspira and irritable bowel syndrome with diarrhoea
por: Jabbar, Karolina S, et al.
Publicado: (2021)

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
por: Garsed, Klara, et al.
Publicado: (2014)

Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit
por: Tooth, David, et al.
Publicado: (2014)

Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management
por: Melchior, Chloé, et al.
Publicado: (2022)

Irritable bowel syndrome: Factors of importance for disease‐specific quality of life
por: Melchior, Chloé, et al.
Publicado: (2022)

European Registry on Helicobacter pylori management: Single‐capsule bismuth quadruple therapy is effective in real‐world clinical practice
por: Nyssen, Olga P., et al.
Publicado: (2021)

European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations
por: Miehlke, Stephan, et al.
Publicado: (2021)

Gastric emptying rate and relevance for symptoms
por: Törnblom, Hans
Publicado: (2023)

Guideline for the diagnosis and treatment of Faecal Incontinence—A UEG/ESCP/ESNM/ESPCG collaboration
por: Assmann, Sadé L., et al.
Publicado: (2022)

A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)
por: Lam, Ching, et al.
Publicado: (2016)

Indian consensus statements on irritable bowel syndrome in adults: A guideline by the Indian Neurogastroenterology and Motility Association and jointly supported by the Indian Society of Gastroenterology
por: Ghoshal, Uday C., et al.
Publicado: (2023)

miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea
por: Martínez, Cristina, et al.
Publicado: (2017)

Disorders of gut‐brain interaction: Highly prevalent and burdensome yet under‐taught within medical education
por: Simons, Julia, et al.
Publicado: (2022)

Inflammatory bowel disease psychological support pilot reduces inflammatory bowel disease symptoms and improves psychological wellbeing
por: Eccles, Jessica Anne, et al.
Publicado: (2020)

Utility of high-resolution anorectal manometry and wireless motility capsule in the evaluation of patients with Parkinson's disease and chronic constipation
por: Su, Andrew, et al.
Publicado: (2016)

Gastrointestinal transit and contractility in diabetic constipation: A wireless motility capsule study on diabetes patients and healthy controls
por: Sangnes, Dag A., et al.
Publicado: (2021)

Epithelial expression and function of trypsin-3 in irritable bowel syndrome
por: Rolland-Fourcade, Claire, et al.
Publicado: (2017)

Gut-focused hypnotherapy for children and adolescents with irritable bowel syndrome
por: Vasant, Dipesh H, et al.
Publicado: (2020)

Work productivity and activity impairment in disorders of gut‐brain interaction: Data from the Rome Foundation Global Epidemiology Study
por: Frändemark, Åsa, et al.
Publicado: (2023)

Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndrome
por: Henström, Maria, et al.
Publicado: (2018)

A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2021)

Irritable bowel syndrome and risk of glaucoma: An analysis of two independent population‐based cohort studies
por: McPherson, Zachary E., et al.
Publicado: (2021)

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain
por: Akbar, A, et al.
Publicado: (2008)

Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome‐wide association study
por: Seeling, Katharina Sophie, et al.
Publicado: (2023)

Construction and validation of a questionnaire distinguishing a chronic abdominal wall pain syndrome from irritable bowel syndrome
por: van Assen, Tijmen, et al.
Publicado: (2012)

Serum L‐arginine and endogenous methylarginine concentrations predict irritable bowel syndrome in adults: A nested case‐control study
por: McEvoy, Mark A., et al.
Publicado: (2021)

Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice
por: Noble, Hithin, et al.
Publicado: (2022)

Assessing telephone-delivered cognitive–behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial
por: Everitt, Hazel Anne, et al.
Publicado: (2019)

Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis—Results from the population‐based DanEoE cohort shows a low complication rate
por: Frandsen, Line Tegtmeier, et al.
Publicado: (2021)

The guts of the matter: UEG's role in European Union health policy developments
por: Dugic, Ana, et al.
Publicado: (2023)

Electroceuticals for Neurogastroenterology and Motility Disorders
por: Jiang, Yan, et al.
Publicado: (2023)

A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia
por: Matsueda, Kei, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6jha1u4mlcn8v67p39kj585h7r